Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 219,937,489 papers from all fields of science
Search
Sign In
Create Free Account
ARC19499
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Aptamers, Nucleotide
BAX499
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Drug-drug interaction of the anti-TFPI aptamer BAX499 and factor VIII: studies of spatial dynamics of fibrin clot formation in hemophilia A.
Leonid A. Parunov
,
Natalia P. Soshitova
,
+8 authors
M. Panteleev
Thrombosis Research
2014
Corpus ID: 205380270
2012
2012
Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia.
M. Gissel
,
T. Orfeo
,
J. Foley
,
S. Butenas
Thrombosis Research
2012
Corpus ID: 2333476
2011
2011
Aptamer ARC 19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor
E. K. Waters
,
Ryan M. J. Genga
,
+5 authors
Kathleen E. McGinness
2011
Corpus ID: 44051559
Hemophilia A and B are caused by deficiencies in coagulation factor VIII (FVIII) and factor IX, respectively, resulting in…
Expand
2010
2010
Inhibition of tissue factor pathway inhibitor (TFPI) by ARC19499 improves clotting of hemophiliac blood
M. Gorczyca
,
B. Jilma
,
C. Male
,
S. Reitter
,
J. Gilbert
,
I. Pabinger
BMC Pharmacology
2010
Corpus ID: 24328277
Background Hemophilia A and B are disorders resulting from a deficiency in factor VIII (FVIII), and factor IX (FIX), respectively…
Expand
2010
2010
TFPI Antagonist Aptamer ARC19499 Is a Procoagulant In Vitro and In Vivo.
Kathleen E. McGinness
,
E. K. Waters
,
+4 authors
R. Schaub
2010
Corpus ID: 208414298
Abstract 1134 Hemophilia is a bleeding disorder that results from deficiencies in coagulation factor VIII (FVIII; hemophilia A…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required